Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Cecilia, Larocca"'
Autor:
Claudia Capurro, Luis Sobrevia, Maria Cecilia Larocca, Graciela Alicia Cremaschi, Martin Vila Petroff
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/396e8fc28cc44b2e8b90b72ec5d3e2dc
Autor:
Laura C Cappelli, Bernice Kwong, Jarushka Naidoo, Jonathan Leventhal, Mario E Lacouture, Meghan J Mooradian, Douglas B Johnson, Justine Cohen, Aparna Hegde, Steven T Chen, Riley Fadden, Leyre Zubiri, Shawn Kwatra, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Yevgeniy R Semenov, Nicole R LeBoeuf, Krista M Rubin, Anna K Dewan, Alina Markova, Allireza Alloo, Daniel Q Bach, Amina Bougrine, Leeann Burton, Mariana Castells, Lauren Guggina, Victor Huang, Benjamin Kaffenberger, Daniela Kroshinsky, Cecilia Larocca, Jon McDunn, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Maxwell Sauder, Sheila Shaigany, Afreen Shariff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
With an increasing number of patients eligible for immune checkpoint inhibitors, the incidence of immune-related adverse events (irAEs) is on the rise. Dermatologic immune-related adverse events (D-irAEs) are the most common and earliest to manifest,
Externí odkaz:
https://doaj.org/article/0f9ad47d419c4ad4b3131ec90c49be9f
Autor:
Neha Gupta, MPH, Cesar A. Virgen, MD, PhD, Amrita Goyal, MD, Andrew A. Lane, MD, PhD, Joseph H. Antin, MD, Sherrie J. Divito, MD, PhD, Cecilia Larocca, MD
Publikováno v:
JAAD Case Reports, Vol 33, Iss , Pp 67-69 (2023)
Externí odkaz:
https://doaj.org/article/8eff8acd2dc94259ab03c75a1d4d7d9f
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Externí odkaz:
https://doaj.org/article/f9630ab6a70442a79c85c3685683ff4e
Publikováno v:
Journal of the American Academy of Dermatology. 88:1164-1166
Autor:
Samantha Jakuboski, Thomas Doyle, Marianne Tawa, David C. Fisher, Nicole LeBoeuf, Cecilia Larocca
Publikováno v:
Current Dermatology Reports. 11:233-243
Autor:
Isabella R. Plumptre, Jordan T. Said, Tiffany Sun, Cecilia Larocca, Cesar A. Virgen, Thomas S. Kupper, David C. Fisher, Philip M. Devlin, Christopher P. Elco, Johanna Sheu Song, Nicole R. LeBoeuf
Publikováno v:
Leukemia & Lymphoma. 63:2832-2846
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD) was reclassified in 2016 as a rare benign entity with an excellent prognosis, yet its clinical features and best treatments remain poorly defined. We collected clini
Autor:
Caterina, Zagona-Prizio, Jenna, Yousif, Carly, Grant, Manan, Mehta, David, Rosmarin, Nanette, Silverberg, Jerry, Tan, Cecilia, Larocca, Michi, Shinohara, Arash, Mostaghimi, Brian, Kim, Susanne, Gulliver, Wayne, Gulliver, Daniel, Siegel, Lourdes, Perez-Chada, Joseph, Merola, Alice, Gottlieb, April, Armstrong
Publikováno v:
Journal of Drugs in Dermatology. 21:867-874
International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenced-based outcome measures to enhance research and treatment recommendations of
Publikováno v:
Journal of the American Academy of Dermatology. 86:1413-1416